Eli Lilly to buy Boston's Kelonia for up to $7 billion
Digest more
Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for Kelonia ...
Hosted on MSN
Eli Lilly to buy Kelonia Therapeutics for up to $7B
Eli Lilly will purchase Kelonia Therapeutics in a deal worth up to $7 billion, gaining its lentiviral in vivo CAR-T platform and multiple myeloma therapy KLN-1010. The acquisition is part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results